Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Forecast 2025 - AI Price Prediction & Analysis

EyePoint Pharmaceuticals, Inc. (EYPT) AI Stock Price Forecast & Investment Analysis

EyePoint Pharmaceuticals, Inc. Stock Price Chart and Technical Analysis

Loading EyePoint Pharmaceuticals, Inc. interactive price chart and technical analysis...

EyePoint Pharmaceuticals, Inc. (EYPT) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

EyePoint Pharmaceuticals, Inc. (Stock Symbol: EYPT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry. The organization employs approximately 157 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $51 million generating a -146.3% net profit margin .

Market Capitalization: $821 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -47.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for EyePoint Pharmaceuticals, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

EyePoint Pharmaceuticals, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . . The company maintains a healthy -226.6% gross margin, indicating strong pricing power and operational efficiency.

EyePoint Pharmaceuticals, Inc. (EYPT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for EyePoint Pharmaceuticals, Inc. stock analysis.

Loading EyePoint Pharmaceuticals, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into EyePoint Pharmaceuticals, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if EyePoint Pharmaceuticals, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For EyePoint Pharmaceuticals, Inc.: With a P/E ratio of -4.43, the market sees the stock as potentially undervalued.

P/E Ratio -4.43x
P/B Ratio 3.34x
Market Cap $821M
EPS $-2.69
Book Value/Share $3.57
Revenue/Share $0.75
FCF/Share $-2.68
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently EyePoint Pharmaceuticals, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EyePoint Pharmaceuticals, Inc.: An ROE of -47.5% indicates room for improvement in shareholder value creation.

ROE -47.5%
ROA -31.1%
ROIC -33.2%
Gross Margin -226.6%
Operating Margin -152.6%
Net Margin -146.3%
EBT Margin -172.5%
Tax Rate 1.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess EyePoint Pharmaceuticals, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For EyePoint Pharmaceuticals, Inc.: A current ratio of 6.87 indicates strong liquidity.

Current Ratio 6.87x
Quick Ratio 6.58x
D/E Ratio 0.18x
Financial Leverage 1.46x
Interest Coverage -11.6x
Working Capital $48M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal EyePoint Pharmaceuticals, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For EyePoint Pharmaceuticals, Inc.: Free cash flow of $-55M indicates cash challenges that need attention.

Operating Cash Flow $-55M
Free Cash Flow $-55M
FCF/Sales -142.5%
CapEx/Sales 0.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively EyePoint Pharmaceuticals, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For EyePoint Pharmaceuticals, Inc.: An asset turnover of 0.18x suggests room for improvement in asset utilization.

Asset Turnover 0.18x
Receivables Turnover 2.4x
Inventory Turnover 1.9x
Fixed Assets Turnover 13.7x
Days Sales Outstanding 150 days
Days Inventory 190 days
Payables Period 280 days
Cash Conversion Cycle 59 days
Understanding Financial Statement Data

What these metrics mean: Key figures from EyePoint Pharmaceuticals, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For EyePoint Pharmaceuticals, Inc.: With annual revenue of $51M, EyePoint Pharmaceuticals, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $51M
Operating Income $-10M
Net Income $-9M
R&D Expense $9M
SG&A Expense $148M
Cost of Goods Sold $-30M
Balance Sheet Highlights ($ Millions)
Total Current Assets $90M
Cash & Short-term Investments $78M
Total Liabilities $32M
Short-term Debt $4M
Accounts Receivable $8M
Inventory $1M
Dividend & Shareholder Information
Shares Outstanding 69M
Growth Metrics (YoY)
EPS Growth -30.6%

Latest EyePoint Pharmaceuticals, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting EyePoint Pharmaceuticals, Inc. (EYPT) stock price and investment outlook.

EyePoint Pharmaceuticals, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of EyePoint Pharmaceuticals, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast $33834M 29.0x 5.5x
AKYA Unlock Forecast $64M -2.1x -10.9x
ASTC Unlock Forecast $8M 28.9x 0.3x
AVTR Unlock Forecast $9071M 13.2x 1.4x
AXDX Unlock Forecast $0M -0.2x 0.0x
BIO Unlock Forecast $8183M 25.6x 1.2x
BIO-B Unlock Forecast $6816M 21.4x 1.0x
BNGO Unlock Forecast $16M 0.0x 0.3x
BRKR Unlock Forecast $6145M 28.3x 3.2x
CTKB Unlock Forecast $531M 82.0x 1.4x
EYPT Unlock Forecast $821M -4.4x 3.3x
HBIO Unlock Forecast $22M -8.3x 1.4x
ILMN Unlock Forecast $15599M 12.4x 6.9x
LAB Unlock Forecast $475M -2.4x 1.1x
LCTC Unlock Forecast $9M x 1.5x
MTD Unlock Forecast $24913M 31.5x -136.9x
NAUT Unlock Forecast $89M -3.8x 0.5x
OMIC Unlock Forecast $50M -1.7x 0.4x
PACB Unlock Forecast $414M -1.5x 6.7x
PRPO Unlock Forecast $22M -1.2x 0.6x
QTRX Unlock Forecast $209M -11.1x 0.7x
RPID Unlock Forecast $123M -0.9x 2.3x
RVTY Unlock Forecast $10846M 38.0x 1.4x
SEER Unlock Forecast $134M -2.0x 0.4x
TXG Unlock Forecast $1729M -8.6x 2.2x
WAT Unlock Forecast $17675M 26.7x 8.2x

Frequently Asked Questions - EyePoint Pharmaceuticals, Inc. Stock Forecast

How accurate are EyePoint Pharmaceuticals, Inc. stock predictions?

Our AI model demonstrates 31% historical accuracy for EYPT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence EyePoint Pharmaceuticals, Inc. stock price forecasts?

Our analysis considers EyePoint Pharmaceuticals, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is EyePoint Pharmaceuticals, Inc. a good investment in 2025?

Based on our AI analysis, EyePoint Pharmaceuticals, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are EyePoint Pharmaceuticals, Inc. forecasts updated?

EyePoint Pharmaceuticals, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced EyePoint Pharmaceuticals, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for EyePoint Pharmaceuticals, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...